Ofloxacin Ophthalmic Solution
Avian Influenza A (H7N9) Virus »
"On April 1, 2013, the World Health Organization (WHO) first reported 3 human infections with a new influenza A (H7N9) virus in China. Since then, additional cases have been reported. Most reported cases have severe respiratory illness and, in som"...
Ofloxacin Ophthalmic Solution
INDICATIONS
Ofloxacin ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below:
| CONJUNCTIVITIS: | ||
| Gram-positive bacteria: | Gram-negative bacteria: | |
| Staphylococcus aureus | Enterobacter cloacae | |
| Staphylococcus epidermidis | Haemophilus influenzae | |
| Streptococcus pneumoniae | Proteus mirabilis Pseudomonas aeruginosa | |
| CORNEAL ULCERS: | ||
| Gram-positive bacteria: | Gram-negative bacteria: | Anaerobic species: |
| Staphylococcus aureus | Pseudomonas aeruginosa | Propionibacterium acnes |
| Staphylococcus epidermidis | Serratia marcescens* | |
| Streptococcus pneumoniae | ||
| *Efficacy for this organism was studied in fewer than 10 infections | ||
DOSAGE AND ADMINISTRATION
The recommended dosage regimen for the treatment of bacterial conjunctivitis is:
Days 1 and 2 ..... Instill one to two drops every two to four
hours in the affected eye(s).
Days 3 through 7 ..... Instill one to two drops four times daily.
The recommended dosage regimen for the treatment of bacterial corneal ulcer is:
Days 1 and 2 .... Instill one to two drops into the affected
eye every 30 minutes, while awake. Awaken at approximately four and six hours
after retiring and instill one to two drops.
Days 3 through 7 to 9 .... Instill one to two drops hourly, while awake.
Days 7 to 9 through treatment completion .... Instill one to two drops, four
times daily.
HOW SUPPLIED
Ofloxacin Ophthalmic Solution is supplied sterile in plastic dropper bottles of the following sizes:
5mL-NDC 17478-713-10
10mL-NDC 17478-713-11
Storage
Store at 20° to 25°C (68° to 77T). [See USP Controlled Room Temperature].
Akorn Inc. Buffalo Grove, IL 60089. FDA Rev date: 5/14/2004
Last reviewed on RxList: 1/21/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Ofloxacin Ophthalmic Solution Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Women's Health
Find out what women really need.
Updated & New
